Back
NLSP
NLS Pharmaceutics Ltd. Ordinary Shares
🇺🇸 NYSE/NASDAQ
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
-5.73%
Annual Growth
5 years average annual capital growth
🌏
5
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
📈 Performance
Price History*
-26.62%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$2.03
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in NLSP
5
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
12 weeks
💵 Average investment amount
$612
⏰ Last time a customer invested in NLSP
25 days
NLSP investor breakdown
💵 Income of investors
More than 200k
25%
150k - 200k
13%
100k - 150k
50k - 100k
50%
Less than 50k
13%
👶 Age of investors
18 - 25
20%
26 - 34
60%
35 - 90
20%
🙋 Legal gender of investors
Female
60%
Male
40%
Pearlers who invest in NLSP also invest in...
🙌 Performance (5Yr p.a)
-7.13%
📊 Share price
$9.52 USD
🙌 Performance (5Yr p.a)
69.42%
📊 Share price
$45.11 USD
🙌 Performance (5Yr p.a)
268.99%
📊 Share price
$176.00 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
62.74%
📊 Share price
$210.50 USD
Want more shares? Try these...